all_task_dict:
  OS: surv
  DFS: surv
  AGE: reg
  AJCC_METASTASIS_PATHOLOGIC_PM: cls
  AJCC_NODES_PATHOLOGIC_PN: cls
  AJCC_STAGING_EDITION: cls
  AJCC_TUMOR_PATHOLOGIC_PT: cls
  BRACHYTHERAPY_TOTAL_DOSE_POINT_A: reg
  BRACHYTHERAPY_TYPE: cls
  BRACHYTHERAPY_TYPE_OTHER: cls
  CERVIX_SUV_RESULTS: reg
  CHEMO_CONCURRENT_COURSE: cls
  CHEMO_CONCURRENT_DOSE: cls
  CHEMO_CONCURRENT_FRACTIONS_TOTAL: cls
  CHEMO_CONCURRENT_REASON_NOT_GIVEN: cls
  CHEMO_CONCURRENT_TYPE: cls
  CHEMO_CONCURRENT_TYPE_OTHER: cls
  CLINICAL_STAGE: cls
  CORPUS_INVOLVEMENT: cls
  CT_SCAN_PREOP_RESULTS: cls
  DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED: reg
  DAYS_TO_DIAGNOSTIC_MRI_PERFORMED: reg
  DAYS_TO_FDG_OR_CT_PET_PERFORMED: reg
  DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS: reg
  DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT: reg
  ECOG_SCORE: reg
  ETHNICITY: cls
  FEDPET_OR_CT_RESULTS: cls
  GRADE: cls
  HEIGHT: reg
  HISTOLOGICAL_DIAGNOSIS: cls
  HISTORY_HORMONAL_CONTRACEPTIVES_USE: cls
  HISTORY_IMMUNOSUPPRESSIVE_DISEASE: cls
  HISTORY_OTHER_MALIGNANCY: cls
  HPV_TYPES_OTHER: cls
  HPV_TYPES_POSITIVE: cls
  HPV_TYPING_METHOD: cls
  HPV_TYPING_METHOD_OTHER: cls
  HYSTERECTOMY_TYPE: cls
  ICD_10: cls
  ICD_O_3_HISTOLOGY: cls
  ICD_O_3_SITE: cls
  INITIAL_PATHOLOGIC_DX_YEAR: reg
  KERATINIZATION_SQUAMOUS_CELL: cls
  LYMPHOVASCULAR_INVOLVEMENT: cls
  LYMPH_NODES_EXAMINED: cls
  LYMPH_NODES_EXAMINED_HE_COUNT: reg
  LYMPH_NODES_EXAMINED_IHC_COUNT: reg
  LYMPH_NODES_SUPRACLAVICULAR: cls
  LYMPH_NODE_EXAMINED_COUNT: reg
  MARGINS_INVOLVED_HYSTERECTOMY: cls
  MENOPAUSE_STATUS: cls
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT: cls
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER: cls
  NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT: cls
  OTHER_HYSTERECTOMY_TYPE: cls
  OTHER_IMMUNOSUPPRESSIVE_DISEASE: cls
  OTHER_INVOLVED_MARGINS: cls
  OTHER_POS_NODE_LOCATION: cls
  PELVIC_EXTENSION_COMMENT: cls
  PERFORMANCE_STATUS_OTHER_TIMING: cls
  PERFORMANCE_STATUS_TIMING: cls
  PHARMACEUTICAL_TX_ADJUVANT: cls
  POS_LYMPH_NODE_LOCATION: cls
  PREGNANCIES_COUNT_ECTOPIC: reg
  PREGNANCIES_COUNT_INDUCED_ABORTION: reg
  PREGNANCIES_COUNT_LIVE_BIRTH: reg
  PREGNANCIES_COUNT_MISCARRIAGE: reg
  PREGNANCIES_COUNT_STILLBIRTH: reg
  PREGNANCIES_COUNT_TOTAL: reg
  PREGNANT_AT_DIAGNOSIS: cls
  PROSPECTIVE_COLLECTION: cls
  RACE: cls
  RADIATION_THERAPY_DOSE_PARAAORTIC_NODES: reg
  RADIATION_THERAPY_XRT_TYPE: cls
  RADIATION_TREATMENT_ADJUVANT: cls
  RADIATION_TYPE_OTHER: cls
  RETROSPECTIVE_COLLECTION: cls
  RT_TX_REASON_NOT_COMPLETED: cls
  RT_TX_REASON_NOT_COMPLETED_OTHER: cls
  RT_TX_TOTAL_DOSE_TO_PELVIS: reg
  SAMPLE_COUNT: reg
  SLIDE_TYPE: cls
  SMOKING_PACK_YEARS: reg
  SMOKING_YEAR_STARTED: reg
  SMOKING_YEAR_STOPPED: reg
  TARGETED_MOLECULAR_THERAPY: cls
  TISSUE_SOURCE_SITE: cls
  TOBACCO_SMOKING_HISTORY_INDICATOR: reg
  TREATMENT_OUTCOME_FIRST_COURSE: cls
  TUMOR_RESPONSE: cls
  TUMOR_STATUS: cls
  WEIGHT: reg
tasks_to_run:
- AGE
- AJCC_METASTASIS_PATHOLOGIC_PM
- AJCC_NODES_PATHOLOGIC_PN
- AJCC_STAGING_EDITION
- AJCC_TUMOR_PATHOLOGIC_PT
- BRACHYTHERAPY_TOTAL_DOSE_POINT_A
- BRACHYTHERAPY_TYPE
- BRACHYTHERAPY_TYPE_OTHER
- CERVIX_SUV_RESULTS
- CHEMO_CONCURRENT_COURSE
- CHEMO_CONCURRENT_DOSE
- CHEMO_CONCURRENT_FRACTIONS_TOTAL
- CHEMO_CONCURRENT_REASON_NOT_GIVEN
- CHEMO_CONCURRENT_TYPE
- CHEMO_CONCURRENT_TYPE_OTHER
- CLINICAL_STAGE
- CORPUS_INVOLVEMENT
- CT_SCAN_PREOP_RESULTS
- DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED
- DAYS_TO_DIAGNOSTIC_MRI_PERFORMED
- DAYS_TO_FDG_OR_CT_PET_PERFORMED
- DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS
- DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT
- DFS_MONTHS
- DFS_STATUS
- ECOG_SCORE
- ETHNICITY
- FEDPET_OR_CT_RESULTS
- GRADE
- HEIGHT
- HISTOLOGICAL_DIAGNOSIS
- HISTORY_HORMONAL_CONTRACEPTIVES_USE
- HISTORY_IMMUNOSUPPRESSIVE_DISEASE
- HISTORY_OTHER_MALIGNANCY
- HPV_TYPES_OTHER
- HPV_TYPES_POSITIVE
- HPV_TYPING_METHOD
- HPV_TYPING_METHOD_OTHER
- HYSTERECTOMY_TYPE
- ICD_10
- ICD_O_3_HISTOLOGY
- ICD_O_3_SITE
- INITIAL_PATHOLOGIC_DX_YEAR
- KERATINIZATION_SQUAMOUS_CELL
- LYMPHOVASCULAR_INVOLVEMENT
- LYMPH_NODES_EXAMINED
- LYMPH_NODES_EXAMINED_HE_COUNT
- LYMPH_NODES_EXAMINED_IHC_COUNT
- LYMPH_NODES_SUPRACLAVICULAR
- LYMPH_NODE_EXAMINED_COUNT
- MARGINS_INVOLVED_HYSTERECTOMY
- MENOPAUSE_STATUS
- METHOD_OF_INITIAL_SAMPLE_PROCUREMENT
- METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER
- NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT
- OS_MONTHS
- OS_STATUS
- OTHER_HYSTERECTOMY_TYPE
- OTHER_IMMUNOSUPPRESSIVE_DISEASE
- OTHER_INVOLVED_MARGINS
- OTHER_POS_NODE_LOCATION
- PELVIC_EXTENSION_COMMENT
- PERFORMANCE_STATUS_OTHER_TIMING
- PERFORMANCE_STATUS_TIMING
- PHARMACEUTICAL_TX_ADJUVANT
- POS_LYMPH_NODE_LOCATION
- PREGNANCIES_COUNT_ECTOPIC
- PREGNANCIES_COUNT_INDUCED_ABORTION
- PREGNANCIES_COUNT_LIVE_BIRTH
- PREGNANCIES_COUNT_MISCARRIAGE
- PREGNANCIES_COUNT_STILLBIRTH
- PREGNANCIES_COUNT_TOTAL
- PREGNANT_AT_DIAGNOSIS
- PROSPECTIVE_COLLECTION
- RACE
- RADIATION_THERAPY_DOSE_PARAAORTIC_NODES
- RADIATION_THERAPY_XRT_TYPE
- RADIATION_TREATMENT_ADJUVANT
- RADIATION_TYPE_OTHER
- RETROSPECTIVE_COLLECTION
- RT_TX_REASON_NOT_COMPLETED
- RT_TX_REASON_NOT_COMPLETED_OTHER
- RT_TX_TOTAL_DOSE_TO_PELVIS
- SAMPLE_COUNT
- SMOKING_PACK_YEARS
- SMOKING_YEAR_STARTED
- SMOKING_YEAR_STOPPED
- TARGETED_MOLECULAR_THERAPY
- TISSUE_SOURCE_SITE
- TOBACCO_SMOKING_HISTORY_INDICATOR
- TREATMENT_OUTCOME_FIRST_COURSE
- TUMOR_RESPONSE
- TUMOR_STATUS
- WEIGHT
- SLIDE_TYPE
label_dict:
  AJCC_METASTASIS_PATHOLOGIC_PM:
    M0: 0
    M1: 1
    MX: 2
  AJCC_NODES_PATHOLOGIC_PN:
    N0: 0
    N1: 1
    NX: 2
  AJCC_STAGING_EDITION:
    '1988': 0
    '1995': 1
    '2009': 2
    5th: 3
    7th: 4
  AJCC_TUMOR_PATHOLOGIC_PT:
    T1a1: 0
    T1b: 1
    T1b1: 2
    T1b2: 3
    T2: 4
    T2a: 5
    T2a1: 6
    T2a2: 7
    T2b: 8
    T3: 9
    T3a: 10
    T3b: 11
    T4: 12
    TX: 13
    Tis: 14
  BRACHYTHERAPY_TYPE:
    HDR: 0
    LDR: 1
    Other: 2
  BRACHYTHERAPY_TYPE_OTHER:
    Implants-tandem and ovoids: 0
    pulse dose rate: 1
    vaginal implant: 2
  CHEMO_CONCURRENT_COURSE:
    Once weekly: 0
    Once weekly|Once weekly: 1
    Once weekly|Once weekly|Once weekly|[Not Available]: 2
    '[Not Available]|[Not Available]': 3
  CHEMO_CONCURRENT_DOSE:
    1000 ml: 0
    40 MG/M2: 1
    40 mg/m2: 2
    40mg: 3
    40mg/m2: 4
    50mg: 5
    56mg/56mL: 6
    57|AUC/5|175mg/m2; 135mg/m2|15mg/kg: 7
    '62': 8
    '68': 9
    '70': 10
    70 mg/m2|750 mg/m2: 11
    70mg: 12
    70mg/m2|1000mg/m2: 13
    75 mg/m2|750 MG/M2: 14
    '[Not Available]|[Not Available]': 15
  CHEMO_CONCURRENT_FRACTIONS_TOTAL:
    '1': 0
    '2': 1
    2|6|6|5: 2
    '3': 3
    3|3: 4
    '4': 5
    4|4: 6
    '5': 7
    '6': 8
    '7': 9
    '[Not Available]|[Not Available]': 10
  CHEMO_CONCURRENT_REASON_NOT_GIVEN:
    Adverse event/ complications: 0
    Not done per treating physicians discretion: 1
    Other: 2
    Participant refusal: 3
    Scheduling problems: 4
  CHEMO_CONCURRENT_TYPE:
    Carboplatin: 0
    Carboplatin|Other: 1
    Cisplatin: 2
    Cisplatin|Carboplatin|Other|Other: 3
    Cisplatin|Other: 4
    Other|Other: 5
  CHEMO_CONCURRENT_TYPE_OTHER:
    Cisplatin|Gemcitabine: 0
    '[Not Applicable]|5 fu RTOG protocol': 1
    '[Not Applicable]|5FU': 2
    '[Not Applicable]|Fluorouracil': 3
    '[Not Applicable]|Fluorouracil (5-FU)': 4
    '[Not Applicable]|Taxol': 5
    '[Not Applicable]|[Not Applicable]|Paclitaxel|Bevacizumab': 6
  CLINICAL_STAGE:
    Stage I: 0
    Stage IA: 1
    Stage IA1: 2
    Stage IB: 3
    Stage IB1: 4
    Stage IB2: 5
    Stage II: 6
    Stage IIA: 7
    Stage IIA1: 8
    Stage IIA2: 9
    Stage IIB: 10
    Stage III: 11
    Stage IIIA: 12
    Stage IIIB: 13
    Stage IVA: 14
    Stage IVB: 15
  CORPUS_INVOLVEMENT:
    ABSENT: 0
    PRESENT: 1
  CT_SCAN_PREOP_RESULTS:
    Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent: 0
    Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available]: 1
    Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent: 2
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 3
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|[Not Available]
    : 4
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent
    : 5
    Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Pelvic Nodes Absent: 6
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 7
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|[Not Available]
    : 8
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 9
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 10
    Bladder Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent: 11
    Bladder Absent|[Not Available]|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent: 12
    Bladder Absent|[Not Available]|Parametrium Absent|[Not Available]|Pelvic Nodes Absent|[Not Available]: 13
    Bladder Absent|[Not Available]|Parametrium Absent|[Not Available]|Pelvic Nodes Present: 14
    ? Bladder Present|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 15
    Bladder Present|Extra-Pelvic Metastatic Disease Absent|Pelvic Nodes Present: 16
    Bladder Present|[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]: 17
    Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent: 18
    Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent: 19
    Extra-Pelvic Metastatic Disease Present: 20
    Extra-Pelvic Metastatic Disease Present|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent: 21
    Extra-Pelvic Metastatic Disease Present|Pelvic Nodes Present: 22
    Pelvic Nodes Present: 23
    ? '[Not Available]|Extra-Pelvic Metastatic Disease Absent|[Not Available]|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent'
    : 24
    '[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent': 25
    '[Not Available]|[Not Available]|[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent': 26
    '[Not Available]|[Not Available]|[Not Available]|[Not Available]|Pelvic Nodes Absent|[Not Available]': 27
    '[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]': 28
  DFS_STATUS:
    0:DiseaseFree: 0
    1:Recurred/Progressed: 1
  ETHNICITY:
    HISPANIC OR LATINO: 0
    NOT HISPANIC OR LATINO: 1
  FEDPET_OR_CT_RESULTS:
    Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent: 0
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 1
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent
    : 2
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 3
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic
      Nodes Present|Pelvic Nodes Present|Supraclavicular Absent
    : 4
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic
      Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent
    : 5
    Bladder Absent|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent: 6
    Bladder Absent|[Not Available]|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available]: 7
    Bladder Absent|[Not Available]|[Not Available]|[Not Available]|Pelvic Nodes Present|[Not Available]: 8
    Extra-Pelvic Metastatic Disease Absent: 9
    ? Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic
      Nodes Absent|Supraclavicular Absent
    : 10
    Extra-Pelvic Metastatic Disease Present: 11
    Paraaortic Nodes Present|Pelvic Nodes Present: 12
    Parametrium Present|Pelvic Nodes Present: 13
    Pelvic Nodes Present: 14
    ? '[Not Available]|Extra-Pelvic Metastatic Disease Absent|[Not Available]|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent'
    : 15
    '[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]': 16
  GRADE:
    G1: 0
    G2: 1
    G3: 2
    G4: 3
    GX: 4
  HISTOLOGICAL_DIAGNOSIS:
    Adenosquamous: 0
    Cervical Squamous Cell Carcinoma: 1
    Endocervical Adenocarcinoma of the Usual Type: 2
    Endocervical Type of Adenocarcinoma: 3
    Endometrioid Adenocarcinoma of Endocervix: 4
    Mucinous Adenocarcinoma of Endocervical Type: 5
  HISTORY_HORMONAL_CONTRACEPTIVES_USE:
    Current User: 0
    Former User: 1
    Never Used: 2
  HISTORY_IMMUNOSUPPRESSIVE_DISEASE:
    HIV: 0
    Other, specify: 1
    '[Not Evaluated]': 2
  HISTORY_OTHER_MALIGNANCY:
    'No': 0
    'Yes': 1
  HPV_TYPES_OTHER:
    18,31,33,35,39,45,51,52,56,58,59,68: 0
    31.33, 35.39, 45.51, 52.56.58.59.68: 1
    '45': 2
    '52': 3
    '58': 4
    '70': 5
    HPV 63: 6
    High risk: 7
    There are several types of HPV the patient could be positive for.: 8
  HPV_TYPES_POSITIVE:
    HPV 16: 0
    HPV 16|HPV 18|Other HPV type(s): 1
    HPV 16|Other HPV type(s): 2
    HPV 18: 3
    Other HPV type(s): 4
  HPV_TYPING_METHOD:
    Other, specify: 0
    PCR: 1
  HPV_TYPING_METHOD_OTHER:
    HPV Hybrid Capture II: 0
    Hybrid Capture 2: 1
    Immunostain: 2
  HYSTERECTOMY_TYPE:
    Other: 0
    Radical Hysterectomy: 1
    Simple Hysterectomy: 2
  ICD_10:
    C53.0: 0
    C53.1: 1
    C53.9: 2
    C56.9: 3
  ICD_O_3_HISTOLOGY:
    8052/3: 0
    8070/3: 1
    8071/3: 2
    8072/3: 3
    8083/3: 4
    8140/3: 5
    8380/3: 6
    8384/3: 7
    8480/3: 8
    8482/3: 9
    8560/3: 10
  ICD_O_3_SITE:
    C53.0: 0
    C53.1: 1
    C53.9: 2
    C56.9: 3
  KERATINIZATION_SQUAMOUS_CELL:
    Keratinizing squamous cell carcinoma: 0
    Non-keratinizing squamous cell carcinoma: 1
  LYMPHOVASCULAR_INVOLVEMENT:
    ABSENT: 0
    PRESENT: 1
  LYMPH_NODES_EXAMINED:
    'NO': 0
    'YES': 1
  LYMPH_NODES_SUPRACLAVICULAR:
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent
    : 0
    ? Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent
    : 1
    Bladder Absent|[Not Available]|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available]: 2
    Bladder Absent|[Not Available]|Parametrium Absent|[Not Available]|Pelvic Nodes Present|[Not Available]: 3
    Extra-Pelvic Metastatic Disease Absent|Parametrium Absent: 4
    Pelvic Nodes Present: 5
    ? '[Not Available]|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic
      Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent'
    : 6
  MARGINS_INVOLVED_HYSTERECTOMY:
    Macroscopic parametrial involvement: 0
    Microscopic parametrial involvement: 1
    Other Location, specify: 2
    Positive bladder margin: 3
    Positive vaginal margin: 4
  MENOPAUSE_STATUS:
    Indeterminate (neither Pre or Postmenopausal): 0
    Peri (6-12 months since last menstrual period): 1
    Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy): 2
    Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement): 3
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT:
    Biopsy (cervical / CT-guided / Other): 0
    Cone Biopsy / LEEP: 1
    Cytology (e.g. Peritoneal or pleural fluid): 2
    Lymph node sampling or dissection: 3
    'Other method, specify:': 4
  METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER:
    D&C: 0
    Dilation & curettage: 1
    Dilation and curettage: 2
    ECC: 3
    Hysterectomy: 4
    Radical Hysterectomy: 5
    Surgery: 6
    Surgical resection: 7
    Tissue in the cervix during pelvic exam was passed ans sent for pathology: 8
    Total Abdominal Hysterectomy: 9
    curettage: 10
    endometrial biopsy: 11
    surgery: 12
    tumor resection: 13
  NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT:
    'NO': 0
    'YES': 1
  OS_STATUS:
    0:LIVING: 0
    1:DECEASED: 1
  OTHER_HYSTERECTOMY_TYPE:
    Radical trachelectomy: 0
    Radical trachelectomy and pelvic lymphadenectomy: 1
    Total Abdominal: 2
    Wertheim Meiggs: 3
    robotic: 4
  OTHER_IMMUNOSUPPRESSIVE_DISEASE:
    Herpes: 0
    Positive for Hepatitis A: 1
  OTHER_INVOLVED_MARGINS:
    Anterior lower uterine segment: 0
    FREE MARGINS: 1
    No involved margins. Margins clear as per pathology report.: 2
    Not involved: 3
    Patient had clear margins: 4
    Squamous cell carcinoma in situ focallly extends to the cervical cuff margin(6-9 o'clock: 5
    Uninvolved margins: 6
    deep cervical: 7
    margins free of tumor: 8
    perineural space invasion: 9
    uninvolved margins: 10
  OTHER_POS_NODE_LOCATION:
    Left External Iliac/Obturator: 0
    Obturator: 1
    Parametrial: 2
    anterior parametrium: 3
    left parametrium: 4
    perigastric: 5
  PELVIC_EXTENSION_COMMENT:
    Bilateral pelvic wall involvement on imaging: 0
    Metastases to Right Ovary: 1
    No pelvic spread: 2
    Pelvic spread: 3
    ? The pelvic nodules show circumscribed area of adipose tissue with local fat
      necrosis. No evidence of malignancy within this pelvic nodule.
    : 4
    Tumor extends 1.0cm into 1.3 cm thick cervical/lower uterine segment wall: 5
    ? carcinoma involves all sections of the cervix with direct extension into the
      myometrial wall, parametrial tissues and upper vagina.
    : 6
    negative: 7
    no extension: 8
    severe squamous dysplasia (CIN3) extending to the vaginal margin of excision: 9
  PERFORMANCE_STATUS_OTHER_TIMING:
    No treatment performed: 0
    Post operative visit: 1
    Post-op: 2
    The patient did not perform treatment: 3
    during adjuvant therapy: 4
  PERFORMANCE_STATUS_TIMING:
    Other: 0
    Post-Adjuvant Therapy: 1
    Pre-Adjuvant Therapy: 2
    Preoperative: 3
  PHARMACEUTICAL_TX_ADJUVANT:
    'NO': 0
    'YES': 1
  POS_LYMPH_NODE_LOCATION:
    Common iliac: 0
    Other Location, specify: 1
    Pelvic (external iliac, internal iliac, obturator): 2
    Pelvic (external iliac, internal iliac, obturator)|Common iliac: 3
    Pelvic (external iliac, internal iliac, obturator)|Common iliac|Para-aortic: 4
    Pelvic (external iliac, internal iliac, obturator)|Other Location, specify: 5
    Pelvic (external iliac, internal iliac, obturator)|Para-aortic: 6
    Pelvic (external iliac, internal iliac, obturator)|Para-aortic|Supraclavicular: 7
  PREGNANT_AT_DIAGNOSIS:
    'NO': 0
    'YES': 1
  PROSPECTIVE_COLLECTION:
    'NO': 0
    'YES': 1
  RACE:
    AMERICAN INDIAN OR ALASKA NATIVE: 0
    ASIAN: 1
    BLACK OR AFRICAN AMERICAN: 2
    NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER: 3
    WHITE: 4
  RADIATION_THERAPY_XRT_TYPE:
    3D conformal: 0
    External beam radiation: 1
    IMRT: 2
    Other: 3
  RADIATION_TREATMENT_ADJUVANT:
    'NO': 0
    'YES': 1
  RADIATION_TYPE_OTHER:
    Whole pelvis split field: 0
    external beam and bilateral parametrial boost: 1
  RETROSPECTIVE_COLLECTION:
    'NO': 0
    'YES': 1
  RT_TX_REASON_NOT_COMPLETED:
    Adverse event/complications: 0
    Not done per treating physician discretion: 1
    Other: 2
    Participant refusal: 3
  RT_TX_REASON_NOT_COMPLETED_OTHER:
    Brain and Pulmonary Metastases leading to death: 0
    Radiation currently ongoing- treatment delayed due to postoperative complication: 1
  SLIDE_TYPE:
    DX1: 0
    DX2: 1
    DX3: 2
    DX4: 3
  TARGETED_MOLECULAR_THERAPY:
    'NO': 0
    'YES': 1
  TISSUE_SOURCE_SITE:
    2W: 0
    4J: 1
    BI: 2
    C5: 3
    DG: 4
    DR: 5
    DS: 6
    EA: 7
    EX: 8
    FU: 9
    GH: 10
    HG: 11
    HM: 12
    IR: 13
    JW: 14
    JX: 15
    LP: 16
    MA: 17
    MU: 18
    MY: 19
    PN: 20
    Q1: 21
    RA: 22
    UC: 23
    VS: 24
    WL: 25
    XS: 26
    ZJ: 27
    ZX: 28
  TREATMENT_OUTCOME_FIRST_COURSE:
    Complete Remission/Response: 0
    Partial Remission/Response: 1
    Progressive Disease: 2
    Stable Disease: 3
  TUMOR_RESPONSE:
    Complete response: 0
    Partial response: 1
    Progression: 2
  TUMOR_STATUS:
    TUMOR FREE: 0
    WITH TUMOR: 1
